EUVIMEDEUVIMED entdecken
Crossref

Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation

Henrique M S Proença iD, Lúcio Requião-Moura iD, Nicolas K Melaragno iD, Renato D Foresto iD, Jose O Medina Pestana iD, Helio Tedesco-Silva iD

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Henrique M S Proença und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Tissue and Organ Procurement, Tissue Donors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Procurement kidney biopsy has been used for over two decades, yet its value in guiding graft acceptance and allocation decisions remains debated. This study evaluated the performance of procurement biopsies in predicting kidney graft function within the first‐year post‐transplantation.

Methods

Retrospective cohort study including 339 procurement biopsies of kidneys transplanted between May 2018 and August 2019. All biopsies were paraffin embedded, stained (H&E, PAS, Jones Silver, and Masson's Trichrome), and prospectively analyzed and deemed suitable for transplantation by an experienced renal pathologist. All biopsies were retrospectively scored according to the Banff, Remuzzi, and MAPI classifications. Logistic regression was used to identify clinical and histological variables associated with unsatisfactory graft function, defined as eGFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGraft RejectionTissue and Organ ProcurementTissue DonorsKidneyKidney Failure, ChronicHumansFemaleMaleRetrospective StudiesMiddle AgedBiopsyPrognosisFollow-Up StudiesGlomerular Filtration RateGraft SurvivalAdultRisk FactorsKidney Function TestsRisk Assessment

Stichwörter der Autor:innen

Banff scoreRemuzzi scoreclinical outcomeskidney graft functionprocurement biopsy

Autor:innen und Institutionen

  • Hospital Do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil.
  • Nephrology Division, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Faculdade De Medicina do ABC, Santo André, São Paulo, Brazil.

ORCID-Profile: Henrique M S Proença, Lúcio Requião-Moura, Nicolas K Melaragno, Renato D Foresto, Jose O Medina Pestana, Helio Tedesco-Silva

Zitieren

APA

Proença, H. M. S., Requião-Moura, L., Melaragno, N. K., Foresto, R. D., Pestana, J. O. M., & Tedesco-Silva, H. (2025). Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70421

Vancouver

Proença HMS, Requião-Moura L, Melaragno NK, Foresto RD, Pestana JOM, Tedesco-Silva H. Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation. Clinical Transplantation. 2025. doi:10.1111/ctr.70421

BibTeX
@article{Proena2025,
  author = {Proença, Henrique M S and Requião-Moura, Lúcio and Melaragno, Nicolas K and Foresto, Renato D and Pestana, Jose O Medina and Tedesco-Silva, Helio},
  title = {Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70421}
}
Kostenlos starten →